# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2044323 | F | Antiviral activity against La Crosse virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect at 5 uM after 4 days by spectrophotometric analysis | La Crosse virus | 2 | organism-based format | Scientific Literature | ||
2. | ALA2044336 | F | Antiviral activity against La Crosse virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect by fluorometric analysis | La Crosse virus | 106 | organism-based format | Scientific Literature | ||
3. | ALA2044425 | F | Antiviral activity against La Crosse virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect at 25 uM during single experiment set up by fluorometric analysis | La Crosse virus | 14 | organism-based format | Scientific Literature | ||
4. | ALA2044432 | F | Antiviral activity against La Crosse virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect during single experiment set up by fluorometric analysis | La Crosse virus | 1 | organism-based format | Scientific Literature | ||
5. | ALA986893 | F | Antiviral activity against La Crosse virus assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days | La Crosse virus | 2 | organism-based format | Scientific Literature | ||
6. | ALA986901 | F | Antiviral activity against La Crosse virus assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days | La Crosse virus | 1 | organism-based format | Scientific Literature | ||
7. | ALA4257361 | F | Antiviral activity against La Crosse virus virus infected in human Be2-c cells assessed as reduction in viral plaque forming units | La Crosse virus | 1 | organism-based format | Patent Bioactivity Data | ||
8. | ALA4422100 | F | Antiviral activity against La Crosse virus infected in human Be2-c cells assessed as reduction in plaque forming units | La Crosse virus | 1 | organism-based format | Patent Bioactivity Data | ||
9. | ALA5259579 | F | Antiviral activity against La Crosse virus infected in African green monkey Vero E6 cells assessed as inhibition of viral replication by visual analysis | La Crosse virus | 1 | organism-based format | Scientific Literature | ||
10. | ALA5259580 | F | Antiviral activity against La Crosse virus infected in African green monkey Vero E6 cells assessed as inhibition of viral replication by neutral red dye based analysis | La Crosse virus | 1 | organism-based format | Scientific Literature |